Ampe investors have opportunity to lead ampio pharmaceuticals, inc. securities fraud lawsuit

Los angeles , oct. 13, 2022 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ampio pharmaceuticals, inc. ("ampio" or the "company") (nyse: ampe). class period: december 29, 2020 – august 3, 2022 lead plaintiff deadline: october 17, 2022 if you wish to serve as lead plaintiff of the ampio lawsuit, you can submit your contact information at www.glancylaw.com/cases/ampio-pharmaceuticals-inc-1/.
AMPE Ratings Summary
AMPE Quant Ranking